| Literature DB >> 29402250 |
Kisughu Munyumu1, Richard Idro2, Catherine Abbo3, Mark Kaddumukasa4, Elly Katabira4, Ezekiel Mupere2, Angelina Kakooza-Mwesige2.
Abstract
BACKGROUND: Sleep plays a prominent role in the growth and development of children. Children with cerebral palsy (CP) are more prone to sleep disorders (SDs) than their peers. Children with CP, have a higher prevalence of disorders involving; initiation and maintenance of sleep, sleep-wake transition, excessive sleepiness and arousal. These sleep disorders impact on the quality of life of these children. Despite, having a high prevalence of CP in Uganda, there is a paucity of data that focuses on sleep disorders in CP, including a lack of prevalence estimates of sleep breathing disorder (SBD) in CP. Understanding the prevalence and disorders of sleep within this population would help advise on the development of tailored interventions to address the needs of these children and improve their quality of life. This study determined the prevalence and associated factors of sleep disorders among children aged 2 - 12 years with cerebral palsy in Uganda.Entities:
Keywords: Sleep Disturbance Scale for Children (SDSC); Uganda; cerebral palsy; children; sleep disorders
Mesh:
Year: 2018 PMID: 29402250 PMCID: PMC5800097 DOI: 10.1186/s12887-018-0996-z
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Baseline demographic characteristics among the study participants
| Frequency | Percentage (%) | |
|---|---|---|
|
| ||
| Yes | 45 | 33 |
| No | 90 | 67 |
|
| ||
| Baganda | 93 | 69 |
| Others | 42 | 31 |
|
| ||
| 2- < 4 | 89 | 66 |
| 4- < 6 | 23 | 17 |
| 6-12 | 23 | 17 |
|
| ||
| Male | 66 | 49 |
| Female | 69 | 51 |
|
| ||
| No schooling/primary | 51 | 38 |
| O level/A level/Higher | 84 | 62 |
Pathological total scores and types of sleep disorders according to sleep disturbance scale for children (SDSC)
| Disorder of initiating and maintaining of sleep (DIMS) | Sleep-Wake Transition Disorder (WTD) | Sleep hyperhidrosis (SHY) | Sleep Breathing Disorder (SBD) | Disorder of Excessive Somnolence (DOES) | Disorder of Arousal (DA) | Total Score (TS) | 95% Confidence Interval (CI) | |
|---|---|---|---|---|---|---|---|---|
| Score range | 7-35 | 6-30 | 2-10 | 3-15 | 5-25 | 3-15 | 26-130 | |
| Mean ± SD | 12.5 ± 7.5 | 8.2 ± 4.0 | 2.9 ± 2.3 | 3.8 ± 2.1 | 6.4 ± 2.9 | 3.2 ± 0.92 | 37.24 ± 15.6 | |
| Cut off | ≥ 17 | ≥ 14 | ≥ 7 | ≥ 7 | ≥ 13 | ≥ 6 | ≥ 51 | |
| Normal sleep | 98 (73) | 117 (87) | 121 (90) | 122 (90) | 124 (92) | 129 (96) | 92 (68) | 60.3-76.0 |
| Pathological sleep | 37 (27) | 18 (13) | 14 (10) | 13 (10) | 11 (8) | 6 (4) | 43 (32) | 24.0-39.7 |
Bivariate analysis for child bio-medical factors (types of CP, MAC, GMFC, CFC and epilepsy) associated with pathological total scores of sleep disturbances
| Variables | Sleep disorders | OR (95% CI) | Chi square | |||
|---|---|---|---|---|---|---|
| Yes (%) | No (%) | |||||
| Types of CP | Bilateral spastic CP | 25(58) | 36(39) | 3.299(1.0-10.9) | 0.05 | 0.152 |
| Unilateral spastic CP | 6(14) | 19(21) | 1.5(0.4-6.2) | 0.575 | ||
| Dyskinetic CP | 8(19) | 18(20) | 2.111(0.5-8.2) | 0.282 | ||
| Ataxic CP/non classified | 4(9) | 19(21) | 1 | |||
| Gross Motor Function Classification (GMFC) | level I | 4(9) | 22(24) | 1 | 0.011 | |
| level II | 5(12) | 20(22) | 1.375(0.3-5.8) | 0.666 | ||
| level III | 2(5) | 11(12) | 1.000(0.2-6.3) | 1 | ||
| level IV | 10(23) | 16(17) | 3.438(0.9-13.0) | 0.068 | ||
| level V | 22(52) | 23(25) | 5.261(1.6-17.7) | 0.007 | ||
| Manual Ability Classification (MAC) | level I | 9(21) | 33(36) | 1 | 0.007 | |
| level II | 4(9) | 16(17) | 0.917(0.2-3.4) | 0.897 | ||
| level III | 0(0) | 4(4) | 1 | |||
| level IV | 5(12) | 15(16) | 1.222(0.3-4.3) | 0.753 | ||
| level V | 25(58) | 24(26) | 3.819(1.5-9.6) | 0.005 | ||
| Communication Function Classification (CFC) | level I | 4(9) | 27(29) | 1 | < 0.001 | |
| level II | 4(9) | 17(18) | 1.588(0.3-7.2) | 0.549 | ||
| level III | 3(7) | 13(14) | 1.558(0.3-8.0) | 0.596 | ||
| level IV | 7(16) | 18(20) | 2.625(0.7-10.3) | 0.166 | ||
| level V | 25(58) | 17(18) | 9.926(2.9-33.5) | < 0.001 | ||
| Epilepsy | Yes | 19(44) | 26(28) | 2.010(0.9-4.3) | 0.07 | 0.067 |
| No | 24(56) | 66(72) | 1 | |||
Bivariate analysis for antiepileptic drugs (AED) and social caregiver factors associated with pathological total scores of sleep disturbances
| Variables | Sleep disorders | OR (95% CI) | Chi square | |||
|---|---|---|---|---|---|---|
| Yes (%) | No (%) | |||||
| Antiepileptic drugs (AED) | Sodium-valproate | 13(68) | 15(58) | 1 | 0.638 | |
| Carbamazepine | 6(32) | 9(35) | 0.769(0.2-2.7) | 0.686 | ||
| Phenytoin | 0(0) | 1(4) | – | |||
| Phenobarbitone | 0(0) | 1(4) | – | |||
| Child educational level | No-school | 43(10) | 87(95) | 0.119 | ||
| Nursery-school | 0(0) | 5(5) | ||||
| Caregiver educational level | No schooling/primary | 15(35) | 36(39) | 1 | 0.635 | |
| O level/A level/Higher | 28(65) | 56(61) | 1.2(0.6-2.6) | 0.636 | ||
| Relationship with the child | Mother | 34(79) | 78(85) | 1 | 0.411 | |
| Other | 9(21) | 14(15) | 1.475(0.6-3.7) | 0.413 | ||
| Bed sharing all night more than 6 months | Yes | 29(67) | 71(77) | 0.613(0.3-1.4) | 0.231 | 0.229 |
| No | 14(33) | 21(23) | 1 | |||
Multivariate model analysis for factors associated pathological total scores of sleep disorders
| Sleep disorders | OR | 95% CI | ||
|---|---|---|---|---|
| Types of CP | Bilateral spastic CP | 11.193 | 2.1-59.0 | 0.004 |
| Unilateral spastic CP | 7.725 | 1.2-51.3 | 0.034 | |
| Dyskinetic CP | 3.570 | 0.7-18.8 | 0.134 | |
| Ataxic CP/non classified | 1 | |||
| Gross motor function | level I | 1 | ||
| level II | 5.714 | 1.0-31.3 | 0.045 | |
| Level III | 1.000 | |||
| level IV | 12.921 | 2.0-82.3 | 0.007 | |
| level V | 13.182 | 3.7-47.0 | < 0.001 | |
| Manual ability | level I | 1 | ||
| level II | 2.338 | 0.4-12.5 | 0.322 | |
| level III | 1.546 | 0.2-12.4 | 0.681 | |
| level IV | 4.509 | 0.9-22.5 | 0.066 | |
| level V | 11.162 | 2.2-56.4 | 0.004 | |
| Relationship with the child | Mother | 1 | ||
| Other | 2.300 | 0.7-7.3 | 0.159 | |
| Bed sharing all night more than 6 months | Yes | 1 | ||
| No | 2.130 | 0.8-5.8 | 0.138 | |
| Epilepsy | Yes | 3.865 | 1.4-10.9 | 0.011 |
| No | 1 | |||